Saturday 17 October 2026
Export DCTH’s income statement to Excel — free account
Delcath Systems, Inc.
DCTH Healthcare Medical Devices
Delcath Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $85.2 million, up 129.1% from fiscal 2024. In the quarter to June 2026, revenue grew 20.6%, EPS fell 12.5% and free cash flow fell 24.5%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
14.08
0.73
−4.93%
Follow DCTH
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
126.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
7 | 6 | 3 | 3 | 5 | 4 | 3 | — | — | 3 |
Altman Z-Score |
13.26 | 17.55 | (19.11) | (41.06) | (17.65) | (14.71) | (41.34) | (84.80) | — | 8,784.82 |
P/S ratio |
4.24 | 9.23 | 32.30 | 11.28 | 15.58 | 31.55 | 0.35 | 2.20 | 0.00 | 256,215.11 |
Altman Z″-Score (non-manufacturers) |
1.26 | (8.72) | (45.05) | (95.97) | (40.83) | (35.27) | (96.44) | (202.52) | (132.97) | (29.37) |
P/FCF ratio |
17.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
(2.73) | 16.41 | (5.01) | 2.87 | (3.07) | (0.37) | 1.12 | (5.44) | (18.12) | (3.14) |
P/Operating CF |
43.86 | (341.23) | (8.16) | (4.17) | (9.19) | (10.30) | (0.10) | (4.07) | 0.00 | (141,145.05) |
P/B ratio |
3.25 | 4.99 | 4.23 | 0.00 | 4.63 | 2.35 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
3.25 | 4.99 | 4.23 | 0.00 | 4.63 | 2.35 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
3.20 | 7.85 | 17.53 | 9.82 | 12.22 | 14.35 | (4.83) | 1.18 | 0.40 | 256,202.42 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.50 | 0.00 | 0.30 | 0.00 |
EV/Operating CF |
12.11 | (15.63) | (1.16) | (1.07) | (1.92) | (1.03) | 0.32 | (0.27) | (0.07) | (35,907.64) |
EV/FCF |
13.01 | (15.18) | (1.16) | (1.06) | (1.91) | (1.00) | 0.32 | (0.27) | (0.07) | (35,267.45) |
Quick Ratio |
9.39 | 10.44 | 1.99 | 0.83 | 4.53 | 2.87 | 0.64 | 0.23 | 0.72 | 0.89 |
Current Ratio |
10.92 | 12.01 | 2.26 | 1.10 | 5.23 | 3.22 | 0.79 | 0.33 | 0.97 | 0.95 |
Net Debt/EBITDA |
132.51 | 4.33 | 0.87 | 0.12 | 0.50 | 1.34 | 0.54 | 0.15 | (1.44) | 16.98 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 43.90% | 45.32% | 1.30% | 14.07% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | (1.34) | 1.26 | 0.02 | (0.31) | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.85 | 0.65 | 0.07 | 0.11 | 0.10 | 0.07 | 0.15 | 0.43 | 0.12 | 0.08 |
Operating CF/Net income |
8.34 | 0.71 | 0.66 | 0.68 | 0.88 | 0.94 | 2.67 | 0.77 | 0.34 | 0.79 |
Capex/Depreciation |
1.15 | (5.48) | (0.06) | (0.23) | (0.30) | (4.68) | (0.01) | (0.02) | (0.02) | (0.02) |
Interest Coverage |
(0.23) | 99.28 | (26.53) | (12.61) | (20.68) | (121.73) | (4.19) | (3.40) | (0.84) | (1.15) |
| 3.00% | (62.44%) | (961.44%) | (1,198.36%) | (150.74%) | (308.01%) | 83.39% | 269.57% | 11,242.36% | (505.44%) | |
| 2.70% | (45.81%) | (168.85%) | (143.21%) | (75.71%) | (99.13%) | (84.34%) | (244.38%) | (206.88%) | (70.51%) | |
ROIC |
2.04% | (50.00%) | 0.00% | 0.00% | (153,318.75%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
2.42% | (38.02%) | (216.11%) | (1,284.59%) | (96.62%) | (102.35%) | 336.07% | 176.25% | (4,253.87%) | 2,099.42% |
Average Days of Receivables |
50.29 | 106.84 | 42.60 | 49.13 | 4.52 | 12.64 | 4.85 | 62.67 | 42.62 | 73.84 |
Research and Development Expense of Revenue |
34.31% | 37.29% | 847.55% | 683.45% | 387.57% | 680.50% | 600.63% | 576.75% | 386.56% | 424.10% |
Selling, General and Administrative Expense of Revenue |
51.07% | 79.43% | 1,070.70% | 636.37% | 383.60% | 674.85% | 713.86% | 288.20% | 356.69% | 473.59% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
28.43% | 26.25% | 394.72% | 292.06% | 220.31% | 237.61% | 17.53% | 1.70% | 4.75% | 21.44% |
Graham Net Nets |
0.30 | 0.19 | 0.21 | (0.25) | 0.18 | 0.38 | (14.45) | (2.12) | 0.00 | 0.00 |
Graham Number |
2.36 | 0.00 | 0.00 | 7.67 | 0.00 | 0.00 | 1,380.15 | 2,104.70 | 0.00 | 1,905,206.61 |
Earnings Yield |
0.79% | (8.14%) | (72.26%) | (114.45%) | (46.84%) | (623.55%) | (1,623.16%) | (256.85%) | (4,355.86%) | (488.77%) |
Free Cash Flow Yield |
5.80% | (5.60%) | (46.94%) | (82.02%) | (41.07%) | (45.54%) | (4,308.52%) | (197.78%) | 0.00% | 0.00% |
Revenue per Share |
2.38 | 1.30 | 0.13 | 0.31 | 0.50 | 0.57 | 61.00 | 89.19 | 0.00 | 415.00 |
Operating CF per Share |
0.63 | (0.66) | (1.93) | (2.81) | (3.16) | (7.89) | (914.63) | (385.65) | 0.00 | (2,961.04) |
Capex per Share |
(0.04) | (0.02) | 0.00 | (0.02) | (0.02) | (0.27) | (0.93) | (1.99) | 0.00 | (53.75) |
Free Cash Flow per Share |
0.59 | (0.67) | (1.93) | (2.84) | (3.18) | (8.16) | (915.56) | (387.64) | 0.00 | (3,014.79) |
Cash per Share |
2.54 | 1.87 | 2.00 | 1.33 | 3.77 | 9.92 | 393.17 | 93.66 | 0.00 | 6,603.33 |
Shareholders Equity per Share |
3.10 | 2.41 | 0.97 | (0.66) | 1.67 | 7.62 | (245.44) | (391.07) | 0.00 | (310.42) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
3.10 | 2.41 | 0.97 | (0.66) | 1.67 | 7.62 | (245.44) | (391.07) | 0.00 | (310.42) |
Free Cash Flow |
20.97 | (19.24) | (31.31) | (25.16) | (22.75) | (23.65) | (23.71) | (14.81) | (15.92) | (14.47) |
Working Capital |
108.58 | 67.62 | 20.71 | 1.42 | 25.20 | 22.30 | (3.38) | (11.83) | (0.22) | (1.94) |
Capital Expenditures |
(1.55) | (0.56) | (0.06) | (0.21) | (0.14) | (0.78) | (0.02) | (0.08) | (0.52) | (0.26) |
Net Current Asset Value |
107.12 | 65.92 | 14.32 | (7.57) | 9.98 | 19.78 | (7.95) | (15.86) | (0.62) | (2.57) |
EV/EBIT |
413.27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.38 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.02 | 0.02 | 0.03 | 0.08 | 0.04 | 0.48 | 0.02 | 0.02 | 0.19 | 0.13 |
Price to Operating Income |
548.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
(0.43) | 0.06 | 0.76 | 0.63 | 0.35 | 0.12 | 6.42 | 3.54 | 16.84 | 13.46 |
Cash ROIC |
10.37% | (15.77%) | (64.85%) | (182.25%) | (42.19%) | (46.12%) | (407.02%) | 130.34% | (265.28%) | (47.91%) |
Accounts Receivable Turnover |
7.53 | 6.68 | 6.80 | 13.26 | 70.40 | 42.21 | 5.21 | 7.55 | 7.54 | 5.86 |
Accounts Payable Turnover |
6.52 | 6.27 | 0.42 | 0.52 | 0.56 | 0.20 | 0.12 | 0.17 | 0.32 | 1.25 |
Inventory Turnover |
1.37 | 1.21 | 0.24 | 0.40 | 0.59 | 0.85 | 0.95 | 0.96 | 0.73 | 0.78 |
Average Days of Payables |
82.24 | 56.68 | 581.70 | 1,073.72 | 347.05 | 1,011.73 | 2,301.18 | 2,790.86 | 2,002.55 | 394.20 |
Days of Inventory on Hand |
317.20 | 408.94 | 1,909.50 | 1,063.08 | 768.08 | 487.62 | 332.00 | 310.38 | 649.81 | 438.00 |
Average Receivables |
11.32 | 5.57 | 0.30 | 0.21 | 0.05 | 0.04 | 0.30 | 0.45 | 0.36 | 0.34 |
Average Payables |
1.81 | 0.99 | 1.52 | 1.33 | 1.21 | 3.15 | 6.12 | 5.78 | 2.22 | 0.44 |
Average Inventory |
8.59 | 5.13 | 2.66 | 1.71 | 1.13 | 0.75 | 0.76 | 1.05 | 0.95 | 0.71 |
Average Assets |
100.11 | 57.60 | 28.24 | 25.49 | 33.88 | 24.42 | 10.53 | 7.87 | 22.06 | 25.49 |
Average Common Equity |
89.98 | 42.26 | 4.96 | 3.05 | 17.02 | 7.86 | (10.65) | (7.13) | (0.41) | 3.56 |
Columns are period end dates